WISeKey’s NFC VaultIC Chips Protect Vaccine Vials by Helping ManufacturesValidate, Authenticate and Track Shipments, and End-Users Verify the Origin of Vials
WISeKey’s NFC VaultIC Chips Protect Vaccine Vials by Helping Manufactures Validate, Authenticate and Track Shipments, and End-Users Verify the Origin of Vials
For more information visit: https://www.wisekey.com/products-services/secure-semiconductors/
Geneva, Switzerland – August 10, 2021 – WISeKey International Holding Ltd (NASDAQ: WKEY; SIX: WIHN), a leading cyber security, IoT, and AI platform company, today announced that is in discussions with several vaccine manufacturers interested to use the WISeKey NFC VaultIC Chips to protect their vaccine vials. VaultIC Chips allow vaccine manufactures to validate, authenticate and track shipments and give end-users the ability to verify the origin of vials.
The VaultIC NFC chips used to authenticate and protect vaccine vials, are tamper-resistant microprocessors built with firmware that enables a number of different cryptographic functions, including authentication. The solution is compatible with a wide variety of algorithms that meet the NIST standards, and supports secret keys and certificates with on-chip data storage capabilities. Other features include a hardware-based True Random Number Generator and a secure software environment that offers protected boot and firmware updates for IoT devices.
VaultIC also supports contactless access and contactless transactions through the use of NFC technology.
WISeKey NFC VaultIC tags can inserted on the vaccine packing boxes or trays that carry vaccine vials. Most vials used for vaccines are made of borosilicate glass, which was invented in 1897 by German chemist and glassmaker Friedrich Otto Schott. It is primarily composed of silica (80 percent) and boric oxide (10 percent), with a small amount of sodium oxide and aluminum oxide also included. This type of glass has remained popular because it is chemically inert.
The NFC VaultIC chips can be attached to the seals of the actual vaccine vials, making it possible to track shipments and verify their origins allowing reading in close proximity with standard NFC phones.
The World Health Organization’s Director-General, Dr. Tedros Adhanom Ghebreyesus, had already issued a warning about counterfeit COVID vaccines being sold on the dark web. This turn of events serves to remind the world about the dramatic impact of drug counterfeiting, a booming organized crime industry growing at the staggering pace of 20% annually. Back in 2017, PwC (conservatively) estimated this black market was worth $200 billion. Currently, more than 10% of drugs sold worldwide are allegedly fake, and in some low-income countries more than 50% of drugs administered to patients are counterfeit; this is resulting in more than 1 million deaths annually, according to Interpol, higher than deaths caused by suicide or illicit drug abuse.
WISeKey’s expertise in the design of NFC secure chips allied with its WISeAuthentic original platform for the identification, authentication, tracking and direct marketing of goods, provides customer-fit solutions for brand protection. Nevertheless, the historic lack of support of NFC tags by iPhones has limited the use of the application by WISeKey’s clients and their end-customers. Apple is now supporting NFC Forum NDEF tags, making WISeKey’s solutions instantly available to millions of users, who can now benefit from advanced security and protection against counterfeiting.
WISeKey (NASDAQ: WKEY; SIX Swiss Exchange: WIHN) is a leading global cybersecurity company currently deploying large scale digital identity ecosystems for people and objects using Blockchain, AI and IoT respecting the Human as the Fulcrum of the Internet. WISeKey microprocessors secure the pervasive computing shaping today’s Internet of Everything. WISeKey IoT has an install base of over 1.5 billion microchips in virtually all IoT sectors (connected cars, smart cities, drones, agricultural sensors, anti-counterfeiting, smart lighting, servers, computers, mobile phones, crypto tokens etc.). WISeKey is uniquely positioned to be at the edge of IoT as our semiconductors produce a huge amount of Big Data that, when analyzed with Artificial Intelligence (AI), can help industrial applications to predict the failure of their equipment before it happens.
Our technology is Trusted by the OISTE/WISeKey’s Swiss based cryptographic Root of Trust (“RoT”) provides secure authentication and identification, in both physical and virtual environments, for the Internet of Things, Blockchain and Artificial Intelligence. The WISeKey RoT serves as a common trust anchor to ensure the integrity of online transactions among objects and between objects and people. For more information, visit www.wisekey.com.
Press and investor contacts:
| WISeKey International Holding Ltd
Company Contact: Carlos Moreira
Chairman & CEO
Tel: +41 22 594 3000
| WISeKey Investor Relations (US)
Contact: Lena Cati
The Equity Group Inc.
Tel: +1 212 836-9611
This communication expressly or implicitly contains certain forward-looking statements concerning WISeKey International Holding Ltd and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of WISeKey International Holding Ltd to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. WISeKey International Holding Ltd is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeKey.